SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-18-000023
Filing Date
2018-12-20
Accepted
2018-12-20 16:40:00
Documents
3
Period of Report
2018-12-20
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20181220x8k.htm 8-K 42000
2 EX-99.1 bpmx-20181220ex991a045c8.htm EX-99.1 7993
3 GRAPHIC bpmx20181220ex991a045c8001.jpg GRAPHIC 57075
  Complete submission text file 0001504167-18-000023.txt   129895
Mailing Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025
Business Address 1505 ADAMS DRIVE, SUITE D MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 181246629
SIC: 2834 Pharmaceutical Preparations